Home > > > PW Consulting Forecast: Phased Array Coil Market to Reach USD 1,270.79 Million by 2032 at 6.32% CAGR

PW Consulting Forecast: Phased Array Coil Market to Reach USD 1,270.79 Million by 2032 at 6.32% CAGR

Author : Ryan Lee | Published On : 16 Jul 2026

Phased Array Coil Market 2026: Strategic Roadmap for Clinical Imaging Leaders

PW Consulting today releases a forward-looking briefing derived from our forthcoming Phased Array Coil Market report — a practical intelligence product designed to inform boardroom decisions and operational plans through 2026. Drawing on a rigorous analysis of historical trends (2020–2025), regulatory context, supplier dynamics, and near-term technology inflection points, this executive brief explains why phased array coils will be a material battleground for MRI vendors, contract manufacturers, and capital allocators over the next planning horizon.
Phased Array Coil Market

Why this market matters for 2026 strategy

Phased array coils are no longer a peripheral accessory; they are core enablers of high-throughput, high-resolution MRI across clinical and research use-cases. Our base-year assessment (2025) and modelled outlook through 2032 show steady, predictable expansion underpinned by parallel imaging adoption, higher-channel architectures, and cross-vendor third-party coil ecosystems. The market is expected to grow at a compound annual growth rate (CAGR) of approximately 6.32% over the forecast window — a pace that rewards focused capability investments and disciplined commercialization strategies.
Phased Array Coil Market

For executives planning 2026 capital allocation, product roadmaps, or M&A targets, three strategic imperatives emerge:
Phased Array Coil Market

  • Prioritise channel density and form-factor innovation that demonstrably raise SNR and patient comfort for target clinical pathways.
  • Build regulatory and compatibility expertise into product development to accelerate time-to-clinic across major scanner platforms.
  • Design commercialization models that capture recurring service and refurbishment revenue alongside OEM and third-party coil sales.

What PW Consulting’s report delivers — practical, board-ready tools

We built the report around the needs of decision-makers who must convert market data into executable plans. The deliverables include:

  • Strategic market sizing and scenario modelling: base-year calibration, upside/downside cases for technology adoption, and sensitivity to reimbursement and regulatory shifts.
  • Competitive diagnostic: capability matrices and supplier positioning frameworks to evaluate OEMs, contract manufacturers, and niche innovators against clinical, regulatory, and commercial criteria.
  • Technology roadmap and R&D playbook: recommended investment sequencing for channel counts, coil flexibility, multi-nuclear tuning, and integration with AI-based reconstruction to accelerate clinical value.
  • Regulatory and go-to-market checklist: stepwise requirements for 510(k)/CE pathways, IEC conformity, platform compatibility validation, and reprocessing/repair protocols that reduce deployment friction.
  • M&A and partnership playbook: target profiles, valuation multipliers, and integration risks for bolt-on coil specialists, contract manufacturers, or diagnostic service partners.
  • Buyers and procurement toolkit: specification templates and lifecycle TCO models for hospitals, imaging centers, and third-party service providers.

Each module is operationally oriented and includes templates and decision trees — not just descriptive text — enabling rapid translation into strategic decisions and project charters.

Competitive landscape: who to watch and why

The market exhibits notable concentration, with the top three players controlling a substantial portion of industry revenues and the top five showing even higher aggregation. This concentration produces both barriers and opportunities: large OEMs bring deep integration into scanner platforms and accelerated regulatory throughput, while mid-size specialists and agile newcomers exploit niche clinical needs, modular designs, and lower-cost refurbishment pathways.

Key players profiled in the report — and the strategic takeaways we draw for 2026 — include:

  • Siemens Healthineers AG (Erlangen, Germany): Integrated coil suites paired with MAGNETOM platforms position Siemens as a system-centric leader. Their emphasis on high-channel-count arrays and flex solutions underscores a platform lock-in strategy that places a premium on cross-sell and upgrade economics.
  • GE HealthCare Technologies, Inc. (Chicago, USA): A portfolio approach across SIGNA platforms highlights neurovascular and high-resolution brain arrays. GE’s strength lies in channel density optimization for mainstream clinical workflows and research applications.
  • Koninklijke Philips N.V. (Amsterdam, Netherlands): Philips’ SENSE-compatible arrays and pediatric-focused partnerships illustrate a combined product-and-experience strategy, where patient comfort and workflow efficiency are used as differentiators.
  • Canon Medical Systems Corporation (Otawara, Japan): Known for clinical performance focus on Vantage systems, Canon’s coils emphasize reliability and integration with clinical imaging suites.
  • United Imaging Healthcare (Shanghai, China): Rapid expansion of high-channel, SuperFlex architectures shows how newer entrants can leapfrog by delivering very high channel counts and aggressive platform compatibility at scale.
  • RAPID Biomedical, InkSpace Imaging, NORAS MRI products and others: these specialists deliver critical innovation around dual-tuned/non-proton coils, ultra-light flexible blankets for pediatrics, and application-specific arrays. They are key acquisition and partnership targets for OEMs seeking faster time-to-market for niche capabilities.
  • Contract manufacturers and service providers such as ScanMed: they represent strategic leverage points to scale production, enable refurbishment models, and extend product lifecycles — an increasingly important margin pool as hardware commoditizes.

Our company dossiers include capability maps, regulatory track records, partnership histories, and recent product/clearance activity — enabling acquirers and partners to triage targets quickly and with confidence.

Recent developments shaping near-term opportunity

The market is being actively reshaped by a series of product clearances and platform integrations. Notable developments captured in our analysis include:

  • Regulatory milestones expanding clinical availability of flexible and pediatric-specific arrays, aligning ergonomics with diagnostic performance.
  • FDA clearances for dual-tuned and very high-channel arrays, which broaden the clinical scope of phased array coils into multi-nuclear and advanced research applications.
  • OEMs and specialist vendors delivering high-channel, “SuperFlex” type architectures that enable whole-body and head & neck imaging with denser channel counts — a trend that is changing procurement specifications and scanner upgrade strategies.

These events are more than product news — they are tactical triggers that change reimbursement dynamics, upgrade cycles, and competitive differentiation in 2026.

Regulatory and reimbursement dynamics you must model

Three regulatory and market-structure realities are particularly material:

  • Classification and clearance pathways: MRI receive coils, including phased array designs, are typically regulated as Class II devices in the U.S. (21 CFR 892.1000) and require substantial-equivalence demonstrations for 510(k) clearance. This creates a predictable but non-trivial time and cost envelope for market entry.
  • Technical safety standards: Compliance with IEC 60601-2-33 and SAR limits during parallel imaging is non-negotiable — technical design decisions that increase channel density must be validated against physiologic heating and scanner control interactions.
  • Reimbursement and adoption: Regions with supportive reimbursement frameworks for high-resolution MRI procedures show materially higher adoption rates for multi-channel phased array solutions — a commercial lever that influences go-to-market sequencing and funding models.

Our report includes a compliance timeline, typical evidentiary dossiers for regulatory submission, and a regional reimbursement sensitivity matrix to quantify time-to-adoption risk.

Practical recommendations for 2026 action plans

Based on scenario modelling and supplier diagnostics, PW Consulting recommends a three-track 18–24 month plan for companies aiming to lead or defend market positions in 2026:

  • Product: Prioritise modular, platform-agnostic phased array designs that simplify cross-vendor compatibility testing and reduce BOM complexity. Invest in patient-centric form factors (e.g., pediatric blankets, lightweight wraps) where clinical differentiation is proof-positive.
  • Regulatory & Quality Operations: Build internal 510(k)/CE submission playbooks and pre-emptive IEC testing programs to shave months from launch timetables. Where feasible, secure early side-by-side compatibility validation with major scanner OEMs.
  • Commercial: Establish hybrid GTM models combining direct OEM channels for integrated systems with authorised third-party distribution and refurbishment services for installed base monetisation.

What we are intentionally withholding — why you should get the full report

To preserve the tactical value of our analysis for clients, this press briefing highlights themes, supplier positioning, and action frameworks but does not disclose granular segmentation tables, region- and application-level market shares, or confidential valuation multiples. These data are included in the full Phased Array Coil Market report and supporting Excel models, which provide the detailed splits and scenario outputs that procurement teams, corporate development groups, and PE investors require to execute with precision.

Next steps

For executive teams preparing 2026 budgets and product roadmaps, the full PW Consulting Phased Array Coil Market report is an actionable toolkit: it combines market sizing, supplier diligence, regulatory playbooks, and M&A/partnership recommendations into a single deliverable designed to shorten decision cycles and reduce execution risk. Contact PW Consulting to request the report, schedule a tailored briefing, or commission a custom deep-dive aligned to your strategic priorities.

PW Consulting — converting market intelligence into executable advantage for the medical imaging ecosystem.

For detailed analysis of this topic, please visit the official page:Phased Array Coil Market

Lacy Lee
Senior Marketing Manager
[email protected]
00852-95632430
PW Consulting: www.pmarketresearch.com